Causes of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia by Pauls, KAM et al.




Left GPi Right GPi
contacts* x y z contacts* x y z
1 3387 Kinetra ®
Recurring ulceration of lead
necessitating complete system
removal and reimplantation




2 3387 Kinetra ® 1-, 3-, C+
-16.8 4.1 -3.7
4-, C+ 19.7 6.5 -2.4
-18.2 5.7 1.9




-19.5 5.6 -2.6 19.2 8.9 0.5




-17.8 4.3 -3.2 18.0 3.2 -4.3




-20.2 6.2 0.4 20.7 4.2 0.3
6 3387 Kinetra ® 0-, C+ -18.9 4.9 -5.8 4-, C+ 21.3 7.3 -5.3
7 3387 Kinetra ® 1-, C+ -19.8 4 -3.9 5-, C+ 19.8 4.4 -4.8
8 3387 Soletra ® 2-, C+ -20.7 7.4 2.1 6-, C+ 20.3 7.4 1.4




-21 6.6 -1.1 21.0 6.6 0.6
10 3387 Activa RC ® 0-, 1- C+
-17 3.7 -4.8
5-, C+ 19.5 6.3 -1.4
-17.3 5.1 -2




-15.9 3.9 -6.1 22.4 6.0 0.8




-20.2 7 -5.6 20.3 6.7 -4




-19.7 6.5 -1.1 20.3 5.4 -2.0




-21.9 10.8 1.1 23.1 8.1 1.5
15 3387 Kinetra ® 1-, C+ -19.1 3.4 0.4 6-, C+ 18.6 5.3 0.6
16 3387 Kinetra ® 2-, C+ -21.7 7 -2.2 6-, C+ 21.0 7.4 2.0




-20.5 6 -3.5 20.2 6.3 -3.3




-19.6 6.6 -1.9 20.5 6.2 -2.3
19 3387 Kinetra ® 1-, C+ -20.1 2.6 -3.1 5-, C+ 19.4 5.0 -3.3
20 3387 Activa RC ®
Perioperative bleeding on right




5-, C+ 19.3 4.6 -3.6
-18.7 4.4 -4.6
21 3387 Kinetra ® 2-,C+ -20.8 7.7 -1.9 4-, 5-, C+ 22.6 1.7 -4.622.8 3.8 -2.5
22 3387 Kinetra ® 0-, C+ -21.5 0.0 1.9 4-, C+ 19.7 4.4 -1.0
23 3387 Kinetra ® 0-, C+ -16.2 6.7 1.2 5-, C+ 18.2 8.3 -4.0
24 3387 Kinetra ® 0-, 1-, C+ n.a. n.a. n.a. 5-, C+ n.a. n.a. n.a.
*note that lead contacts have been numbered in a standardized fashion from 0 to 4 (left, bottom to top) and 4 to 7 (right, bottom to top) regardless of generator system
Supplementary Table 2 Stimulation settings
Pat. no.
Left GPi Right GPi













2 90 130 792 59.1 4-,5-,6-, C+ 0.6 210 130 792 12.4
2
1-, 3-, C+
1 210 130 660 (contact 2:>4000 Ohm) 41.4
4-, C+
1 210 130 953 28.6
3
0-, 1-, C+
1.5 120 145 650 60.2 5-, 6-, C+ 3 120 145 980 159.8
4
0-, 1-, C+
2 150 210 681 185.0 4-, 5-, C+ 2 150 210 681 185.0
5
0-, 1-, C+
1.45 60 125 901 17.5 4-,5-, C+ 1.8 60 125 1020 23.8
6
0-, C+
3.7 90 150 737 250.8 4-, C+ 4.7 120 150 835 476.2
7
1-, C+
2.2 210 130 501 263.7 5-, C+ 2 210 130 612 178.4
8
2-, C+
2.5 210 185 895 271.3 6- C+ 3 180 130 767 274.6
9
1-, 2+
5.5 210 130 1029 802.6 5-, 6+ 5.5 210 130 928 889.9
10
0-, 1- C+
2.95 120 125 923 141.4 5-, C+ 3 120 125 962 140.3
11
0-, 1+
2.5 180 130 998 146.5 6-, 7+ 3 180 130 1203 175.1
12
1-, 2+
4.5 240 180 959 912.2 5-, 6+ 4.5 240 180 959 912.2
13
1-, 2+
4.7 210 130 910 662.7 4-,5+ 4.3 210 130 931 542.2
14
1-, 3+
3.8 210 130 1154 341.6 5-, 7+ 3.8 210 130 1787 220.6
15
1-, C+
2.7 210 210 551 583.5 6-, C+ 2.7 210 210 551 583.5
16
2-, C+
3.8 150 210 525 866.4 6-, C+ 1.8 150 210 635 160.7
17
1-, 2+
6.3 240 130 960 1289.9 5-,6+ 6.3 240 130 1353 915.2
18
0-, 1-, C+
1.4 120 125 1400 21.0 4-,5-, C+ 1.5 120 125 1650 20.5
19
1-, C+
1.8 210 130 919 96.2 5-, C+ 1.8 210 130 919 96.2
20
0-, 1-, C+
0.75 60 125 2716 1.6 5-, C+ 0.9 60 125 2020 3.0
21 2-,C+ 3.8 120 130 700 321.8 4-,5- C+ 3.8 120 130 1000 225.3
22 0-, C+ 3 120 180 797 243.9 4-, C+ 4 120 180 1069 323.3
23 0-, C+ 3 90 130 789 133.5 5-, C+ 3 90 130 789 133.5
24 0-, 1-, C+ 3.3 90 167 1395 117.3 5-, C+ 2.6 90 167 1395 72.8
mean n=1.7
3.0 150.0 150.3 960.1 326.3
n=1.6
3.0 155.5 147.8 1057.3 281.4
*note that lead contacts have been numbered in a standardized fashion from 0 to 3 (left, bottom to top) and 4 to 7 (right, bottom to top) regardless of generator system
Supplementary Table 3 Additional diagnostic findings







1 normal negative normal negative normal 141 15 30
2 normal negative pathological DaT-Scan normal negative normal 134 18 30
3 Flair hyperintensities negative normal negative normal 143 17 30
4 normal positive (tremor) normal DaT-Scan normal negative normal 142 13 29
5 normal negative GAD-autoantibodies in
serum and CSF, isolated
motor polyneuropathy
normal negative normal 143 18 n.a.
6 normal negative normal negative normal 144 18 n.a.
7 normal negative normal negative normal 144 15 30
8 marked brain atrophy with
maximum frontally, otherwise
normal, no basal ganglia
pathology
negative Cu 32,5 negative normal 127 12 29
9 slight brain atrophy, otherwise
normal
positive (3min) CSF normal normal 3x2/1000 Eryt. normal 130 16 30
10 normal negative normal negative normal 139 15 25
11 normal negative normal negative normal 134 9 28
12 multiple T2 hyperintense white
matter lesions bilaterally
negative CSF type II oligoclonal
bands
normal negative normal 142 17 30
13 normal negative normal negative normal 144 14 30
14 normal negative normal negative normal 138 18 28
15 T2 hyperintense putaminal
lesions bilaterally
negative pathological DaT-Scan normal 1x1/1000 Eryt. normal * * *
16 normal negative normal negative normal 139 10 n.a.
17 normal negative normal negative normal 139 14 29
18 normal negative normal negative normal 135 10 28
19 T2-hyperintense lesion right crus
cerebri (post thalamotomy)
negative normal negative normal 143 14 30
20 normal negative CSF normal normal negative normal 141 16 29
21 normal limited response normal negative n.a. 132 (preop.) n.a. n.a.
22 normal negative CSF normal normal negative n.a. 130 (preop.) n.a. n.a.
23 normal n.a. CSF normal n.a. n.a. normal 128 7 30
24 normal n.a. n.a. n.a. n.a. n.a. n.a. n.a.
mean 138.5 14.3 29.1
* standard testing not possible due to anarthria, Benton-Test 12/15

